CTXR
Price
$3.30
Change
+$0.04 (+1.23%)
Updated
Jan 17 closing price
Capitalization
27.95M
20 days until earnings call
EYEN
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
Jan 17 closing price
Capitalization
6.98M
67 days until earnings call
Ad is loading...

CTXR vs EYEN

Header iconCTXR vs EYEN Comparison
Open Charts CTXR vs EYENBanner chart's image
Citius Pharmaceuticals
Price$3.30
Change+$0.04 (+1.23%)
Volume$78.6K
Capitalization27.95M
Eyenovia
Price$0.06
Change-$0.01 (-14.29%)
Volume$34.89M
Capitalization6.98M
CTXR vs EYEN Comparison Chart
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. EYEN commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and EYEN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (CTXR: $3.30 vs. EYEN: $0.06)
Brand notoriety: CTXR and EYEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 21% vs. EYEN: 101%
Market capitalization -- CTXR: $27.95M vs. EYEN: $6.98M
CTXR [@Biotechnology] is valued at $27.95M. EYEN’s [@Biotechnology] market capitalization is $6.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileEYEN’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • EYEN’s FA Score: 0 green, 5 red.
According to our system of comparison, CTXR is a better buy in the long-term than EYEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while EYEN’s TA Score has 4 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 4 bearish.
  • EYEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EYEN is a better buy in the short-term than CTXR.

Price Growth

CTXR (@Biotechnology) experienced а -9.09% price change this week, while EYEN (@Biotechnology) price change was -42.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CTXR is expected to report earnings on Feb 07, 2025.

EYEN is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTXR($28M) has a higher market cap than EYEN($6.98M). CTXR YTD gains are higher at: -17.500 vs. EYEN (-57.123). EYEN has higher annual earnings (EBITDA): -34.09M vs. CTXR (-40.86M). EYEN has more cash in the bank: 7.19M vs. CTXR (212). CTXR has less debt than EYEN: CTXR (320K) vs EYEN (13M). EYEN has higher revenues than CTXR: EYEN (31.8K) vs CTXR (0).
CTXREYENCTXR / EYEN
Capitalization28M6.98M401%
EBITDA-40.86M-34.09M120%
Gain YTD-17.500-57.12331%
P/E RatioN/AN/A-
Revenue031.8K-
Total Cash2127.19M0%
Total Debt320K13M2%
FUNDAMENTALS RATINGS
CTXR vs EYEN: Fundamental Ratings
CTXR
EYEN
OUTLOOK RATING
1..100
2585
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6598
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for EYEN (51). This means that CTXR’s stock grew somewhat faster than EYEN’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EYEN (100). This means that CTXR’s stock grew similarly to EYEN’s over the last 12 months.

CTXR's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as EYEN (100). This means that CTXR’s stock grew similarly to EYEN’s over the last 12 months.

CTXR's Price Growth Rating (65) in the Pharmaceuticals Major industry is somewhat better than the same rating for EYEN (98). This means that CTXR’s stock grew somewhat faster than EYEN’s over the last 12 months.

CTXR's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as EYEN (100). This means that CTXR’s stock grew similarly to EYEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXREYEN
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
82%
Momentum
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
81%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
86%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
79%
Aroon
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN114.161.21
+1.07%
Stride
SAMG17.990.14
+0.78%
Silvercrest Asset Management Group
UHAL71.630.36
+0.51%
U-Haul Holding Company
HOUS3.38-0.12
-3.43%
Anywhere Real Estate
VVOS5.74-0.21
-3.53%
Vivos Therapeutics

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with EYEN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then EYEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+1.23%
EYEN - CTXR
48%
Loosely correlated
-5.15%
TFFP - CTXR
37%
Loosely correlated
N/A
ALLO - CTXR
31%
Poorly correlated
-1.09%
ALEC - CTXR
31%
Poorly correlated
+1.79%
PBYI - CTXR
30%
Poorly correlated
-1.66%
More

EYEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYEN has been loosely correlated with CTXR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if EYEN jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYEN
1D Price
Change %
EYEN100%
-5.15%
CTXR - EYEN
48%
Loosely correlated
+1.23%
TFFP - EYEN
48%
Loosely correlated
N/A
HALO - EYEN
35%
Loosely correlated
-1.03%
VACBF - EYEN
32%
Poorly correlated
N/A
ALEC - EYEN
30%
Poorly correlated
+1.79%
More